Viewing Study NCT00627666


Ignite Creation Date: 2025-12-24 @ 4:02 PM
Ignite Modification Date: 2025-12-27 @ 9:48 AM
Study NCT ID: NCT00627666
Status: COMPLETED
Last Update Posted: 2013-03-26
First Post: 2008-02-29
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Donor Stem Cell Transplant After Busulfan, Fludarabine, and Antithymocyte Globulin in Treating Patients With Hematological Cancer
Sponsor: Asan Medical Center
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Leukemia View
None Myelodysplastic Syndromes View
None Myelodysplastic/Myeloproliferative Neoplasms View
Keywords:

Keywords

Keyword Brief Keyword Text View
None adult acute lymphoblastic leukemia in remission View
None recurrent adult acute lymphoblastic leukemia View
None untreated adult acute lymphoblastic leukemia View
None adult acute myeloid leukemia in remission View
None recurrent adult acute myeloid leukemia View
None untreated adult acute myeloid leukemia View
None acute lymphocytic leukemia View
None secondary acute myeloid leukemia View
None acute undifferentiated leukemia View
None mast cell leukemia View
None accelerated phase chronic myelogenous leukemia View
None blastic phase chronic myelogenous leukemia View
None chronic phase chronic myelogenous leukemia View
None meningeal chronic myelogenous leukemia View
None relapsing chronic myelogenous leukemia View
None chronic myelomonocytic leukemia View
None adult acute myeloid leukemia with 11q23 (MLL) abnormalities View
None adult acute myeloid leukemia with inv(16)(p13;q22) View
None adult acute myeloid leukemia with t(15;17)(q22;q12) View
None adult acute myeloid leukemia with t(16;16)(p13;q22) View
None adult acute myeloid leukemia with t(8;21)(q22;q22) View
None de novo myelodysplastic syndromes View
None previously treated myelodysplastic syndromes View
None secondary myelodysplastic syndromes View
None atypical chronic myeloid leukemia, BCR-ABL1 negative View
None myelodysplastic/myeloproliferative neoplasm, unclassifiable View
None refractory anemia with excess blasts in transformation View
None refractory anemia with excess blasts View